Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients
Circulating tumor cells (CTCs) have been studied using multiple technical approaches for interrogating various cancers, as they allow for the real-time assessment of tumor progression, disease recurrence, treatment response, and tumor molecular profiling without the need for a tumor tissue biopsy. H...
Main Authors: | Yoshiaki Shoji, Matias A. Bustos, Rebecca Gross, Dave S. B. Hoon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/4/859 |
Similar Items
-
Circulating miRNAs as biomarkers for the diagnosis in patients with melanoma: systematic review and meta-analysis
by: Nicholas Jones, et al.
Published: (2024-02-01) -
Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy
by: Valentina Aleotti, et al.
Published: (2021-12-01) -
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma
by: Anthony Lucci, et al.
Published: (2023-07-01) -
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
by: Kartik Anand, et al.
Published: (2019-06-01) -
Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
by: Katharina Gorges, et al.
Published: (2019-10-01)